Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m

Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m

A stable, amorphous, lyophilized dihydrochloride salt of 7-( alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidi nium)methyl]-3-cephem-4-carboxylate is described. This lyophilized salt is more easily prepared than the crystalline counterpart and can be reconstitu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KAPLAN, MURRAY A, NASSAR, MUNIR N
Format: Patent
Sprache:dan
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KAPLAN, MURRAY A
NASSAR, MUNIR N
description A stable, amorphous, lyophilized dihydrochloride salt of 7-( alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidi nium)methyl]-3-cephem-4-carboxylate is described. This lyophilized salt is more easily prepared than the crystalline counterpart and can be reconstituted in effective concentrations for intramuscular and intravenous injection utilizing suitable organic and inorganic bases to pH 3-7.0.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK0386668TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK0386668TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK0386668TT33</originalsourceid><addsrcrecordid>eNqNzL0KwjAUhuEuDqLeQ93a4YA1Urv7g6BjJ4tIaE7IgbSnpBGM3rz15wKcvuF9-MbR8xRYk6UeHfpYkQnKcW0sO1Kx1PEaKmm1hGQJsqGWvSH5YAsrCDaFbzqn0KA3fA_0JrJGP1jFFxBQJdknBgsZdME5tqSopVuTNtNopKXtcfbbSTTf78rNAbDjK_bdcNSiv26PC1HkeV6UpRD_mBfIjEY1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m</title><source>esp@cenet</source><creator>KAPLAN, MURRAY A ; NASSAR, MUNIR N</creator><creatorcontrib>KAPLAN, MURRAY A ; NASSAR, MUNIR N</creatorcontrib><description>A stable, amorphous, lyophilized dihydrochloride salt of 7-( alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidi nium)methyl]-3-cephem-4-carboxylate is described. This lyophilized salt is more easily prepared than the crystalline counterpart and can be reconstituted in effective concentrations for intramuscular and intravenous injection utilizing suitable organic and inorganic bases to pH 3-7.0.</description><edition>6</edition><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990719&amp;DB=EPODOC&amp;CC=DK&amp;NR=0386668T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990719&amp;DB=EPODOC&amp;CC=DK&amp;NR=0386668T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAPLAN, MURRAY A</creatorcontrib><creatorcontrib>NASSAR, MUNIR N</creatorcontrib><title>Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m</title><description>A stable, amorphous, lyophilized dihydrochloride salt of 7-( alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidi nium)methyl]-3-cephem-4-carboxylate is described. This lyophilized salt is more easily prepared than the crystalline counterpart and can be reconstituted in effective concentrations for intramuscular and intravenous injection utilizing suitable organic and inorganic bases to pH 3-7.0.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzL0KwjAUhuEuDqLeQ93a4YA1Urv7g6BjJ4tIaE7IgbSnpBGM3rz15wKcvuF9-MbR8xRYk6UeHfpYkQnKcW0sO1Kx1PEaKmm1hGQJsqGWvSH5YAsrCDaFbzqn0KA3fA_0JrJGP1jFFxBQJdknBgsZdME5tqSopVuTNtNopKXtcfbbSTTf78rNAbDjK_bdcNSiv26PC1HkeV6UpRD_mBfIjEY1</recordid><startdate>19990719</startdate><enddate>19990719</enddate><creator>KAPLAN, MURRAY A</creator><creator>NASSAR, MUNIR N</creator><scope>EVB</scope></search><sort><creationdate>19990719</creationdate><title>Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m</title><author>KAPLAN, MURRAY A ; NASSAR, MUNIR N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK0386668TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1999</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KAPLAN, MURRAY A</creatorcontrib><creatorcontrib>NASSAR, MUNIR N</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAPLAN, MURRAY A</au><au>NASSAR, MUNIR N</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m</title><date>1999-07-19</date><risdate>1999</risdate><abstract>A stable, amorphous, lyophilized dihydrochloride salt of 7-( alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidi nium)methyl]-3-cephem-4-carboxylate is described. This lyophilized salt is more easily prepared than the crystalline counterpart and can be reconstituted in effective concentrations for intramuscular and intravenous injection utilizing suitable organic and inorganic bases to pH 3-7.0.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK0386668TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Lyofiliseret dihydrochlorid af 7-[alfa-(2-aminothiazol-4-yl)-alfa-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)m
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A08%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAPLAN,%20MURRAY%20A&rft.date=1999-07-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK0386668TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true